Surf Wiki
Save to docs
general/g-protein-coupled-receptors

From Surf Wiki (app.surf) — the open knowledge base

Thrombin receptor

Thrombin receptor

There are three known thrombin receptors (ThrR), termed PAR1, PAR3 and PAR4 (PAR for protease-activated receptor).

Activation of PARs

G-protein-coupled receptors that are responsible for the coagulation effects and responses of thrombin on cells are known as protease-activated receptors, or PARs. These receptors are members of the 7-transmembrane g protein-coupled family of receptors, however, their method of activation is unique. Unlike most G-protein-coupled receptors, PARs are irreversibly activated by proteolytic mechanism and therefore, are strictly regulated.

Thrombin is an allosteric serine protease that is an essential effector of coagulation that is produced at sites of vascular injury and plays a critical role in cellular response to blood-related diseases. It binds to and cleaves the extracellular N-terminal domain of the receptor. A tethered ligand corresponding to the new N-terminus, SFLLRN, is then unmasked, binding to the second extracellular loop of the receptor and activating it.

Tissue distribution

PAR1, PAR3, and PAR4 are activated by thrombin. There are species-specific differences in thrombin receptor expression in platelets and other cell types, in which differences in thrombin concentrations may considerably affect platelet activation of distinct PARs. As seen in human platelets, PAR1 and PAR4 are the functional thrombin receptors, whereas PAR3 and PAR4 are functional thrombin receptors in mouse platelets

Thrombin receptors are also differentially expressed in cell types, e.g. PAR1 is expressed in fibroblasts, smooth muscle cells, sensory neurons and glial cells, whereas the other two are less clearly defined.

There are various roles depending on location of activation. Fibroblasts and smooth muscle cells induces growth factor and matrix production, migration and proliferation. Sensory neurons induces proliferation and release of neuroactive agents.

Regulation of signaling

Desensitization and internalization

Initial desensitization due to rapid phosphorylation of activated receptors by kinases, which increases affinity for arrestin. Arrestin prevents protein-receptor interaction and the receptor becomes dephosphorylated and inhibited from signaling. This is a sufficient and rapid form of termination of PAR signaling. Irreversibly activated PAR1 is internalized and terminated from further signaling by clathrin-mediated endocytosis and lysosome degradation, preventing replenishment at the cell surface.

Biased signaling is a form of regulating thrombin receptors by allowing specific ligands to activate certain pathways. It is known that thrombin activates PAR1 signaling, which can activate many pathways involving the G-protein-coupled receptors, however, with biased signaling it is different. Biased antagonists made for thrombin receptors are important for therapeutical therapies that can treat different inflammatory-related diseases. There have been studies of PAR-1 inhibitors, vorapaxar and atopaxar, which could provide an alternative treatment for atherothrombotic disease.

References

References

  1. (December 1996). "Biological consequences of thrombin receptor deficiency in mice". Thrombosis and Haemostasis.
  2. (July 2010). "Thrombin receptors and their antagonists: an update on the patent literature". Expert Opinion on Therapeutic Patents.
  3. (December 2019). "Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases". Thrombosis Journal.
  4. (2018). "Hematology". Elsevier.
  5. (2013). "Platelets". Elsevier.
  6. (August 1998). "A dual thrombin receptor system for platelet activation". Nature.
  7. (2009). "Thrombin". Springer New York.
  8. Hollenberg, M D. (2014). "Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease". British Journal of Pharmacology.
  9. Tello-Montoliu, Antonio. (2011). "Antiplatelet therapy: thrombin receptor antagonists". British Journal of Clinical Pharmacology.
Info: Wikipedia Source

This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.

g-protein-coupled-receptors
Want to explore this topic further?

Ask Mako anything about Thrombin receptor — get instant answers, deeper analysis, and related topics.

Research with Mako

Free with your Surf account

Content sourced from Wikipedia, available under CC BY-SA 4.0.

This content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.

Report